Cargando…
Nanomedicine for Gene Delivery for the Treatment of Cardiovascular Diseases
BACKGROUND: Myocardial infarction (MI) is the most severe ischemic heart disease and di-rectly leads to heart failure till death. Target molecules have been identified in the event of MI including increasing angiogenesis, promoting cardiomyocyte survival, improving heart function and restraining inf...
Autores principales: | Yan, Cen, Quan, Xiao-Jiang, Feng, Ying-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751340/ https://www.ncbi.nlm.nih.gov/pubmed/30280665 http://dx.doi.org/10.2174/1566523218666181003125308 |
Ejemplares similares
-
Nanomedicine in pulmonary delivery
por: Mansour, Heidi M, et al.
Publicado: (2009) -
Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies
por: Andreana, Ilaria, et al.
Publicado: (2021) -
Targeted Delivery of Nanomedicines
por: Kumar Khanna, Vinod
Publicado: (2012) -
Nanomedicines for the Delivery of Biologics
por: Wahlich, John, et al.
Publicado: (2019) -
Anti-inflammatory Nanomedicine for Cardiovascular Disease
por: Katsuki, Shunsuke, et al.
Publicado: (2017)